Lannett Company
LCI
#10382
Rank
NZ$12.77 M
Marketcap
NZ$1.19
Share price
0.00%
Change (1 day)
-69.39%
Change (1 year)

Lannett Company (LCI) - Total debt

Total debt on the balance sheet as of March 2023 : NZ$1.10 Billion

According to Lannett Company's latest financial reports the company's total debt is NZ$1.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lannett Company - Total debt on balance sheet (from 1999 to 2023)

Total debt by year

Year Total debt Change
2022-06-30NZ$1.00 B16.44%
2021-06-30NZ$0.86 B-19.56%
2020-06-30NZ$1.07 B-1.07%
2019-06-30NZ$1.08 B-12.5%
2018-06-30NZ$1.23 B0.41%
2017-06-30NZ$1.23 B-17.05%
2016-06-30NZ$1.48 B99987.91%
2015-06-30NZ$1.48 M14.47%
2014-06-30NZ$1.29 M-84.57%
2013-06-30NZ$8.41 M-5.66%
2012-06-30NZ$8.92 M-5.5%
2011-06-30NZ$9.44 M-15.39%
2010-06-30NZ$11.16 M-12.09%
2009-06-30NZ$12.69 M7.56%
2008-06-30NZ$11.8 M-6.27%
2007-06-30NZ$12.59 M-6.96%
2006-06-30NZ$13.53 M-2.89%
2005-06-30NZ$13.93 M-11.68%
2004-06-30NZ$15.78 M196.57%
2003-06-30NZ$5.32 M-37.58%
2002-06-30NZ$8.52 M-67.83%
2001-06-30NZ$26.49 M95.88%
2000-06-30NZ$13.52 M-22.99%
1999-06-30NZ$17.56 M-16.75%
1998-06-30NZ$21.09 M59.14%
1997-06-30NZ$13.25 M25.84%
1996-06-30NZ$10.53 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$105.32 B 9,413.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 7,059.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$22.40 B 1,923.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.43 B 4,906.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$41.30 B 3,630.61%๐Ÿ‡ฌ๐Ÿ‡ง UK